Streetbeat News

Revenues

KZIA

Kazia Therapeutics Limited (NASDAQ:KZIA) will present new data from its lead program, paxalisib, at the 21st International Symposium on Pediatric Neuro-Oncology (ISPNO 2024) from June 29 to July 2, 2024. Additionally, an article in the European Journal of Cancer highlights the need for mutation-specific, CNS-penetrant inhibitors to treat pediatric patients with Diffuse Midline Glioma (DMG).

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:17 pm

TSLA

Elon Musk predicts Tesla could reach a $24 trillion market cap by 2034, driven by robotaxis and Optimus robots. Musk agrees with a shareholder's forecast of Tesla operating 100 million robotaxis and over a billion robots by then. Tesla's communication strategy relies heavily on Musk and social media, as it lacks a dedicated PR department.

Portfolio Pulse from Anan Ashraf

June 27, 2024 | 12:04 pm

LGND

Ligand Pharmaceuticals has announced FDA approval for Ohtuvayre, a new COPD treatment. This approval increases their commercial stage portfolio to 11 products. Ligand will receive a $5.8M milestone payment and anticipates an additional $13.8M upon the commercial launch. The company is also entitled to low single-digit royalties on global sales.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:04 pm

ACLS

EWJ

Axcelis Technologies has established new service offices in Chitose and Kumamoto to support its expanding customer base in Japan.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 12:03 pm

CRGY

Over the past three months, analysts have shared mixed opinions on Crescent Energy (NYSE:CRGY), with ratings ranging from bullish to indifferent. The average 12-month price target has decreased to $17.8 from $18.50. Key analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance. Crescent Energy has shown notable revenue growth but faces challenges in profitability, return on equity, and debt management.

Portfolio Pulse from Benzinga Insights

June 27, 2024 | 12:01 pm

J

Jacobs Solutions has been selected by Fujifilm Diosynth Biotechnologies to support the delivery of a $1.2 billion expansion of a large-scale cell culture contract manufacturing site in Holly Springs, North Carolina.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:53 am

ARAY

Heidelberg University Hospital in Germany has chosen Accuray's Radixact System, which includes ClearRT, Synchrony, and VOLO Ultra Optimizer solutions, to replace its older Accuray Tomotherapy system.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:37 am

IP

LEVI

MU

NVDA

QQQ

SPY

Wall Street is set for a weak opening as the tech rally falters, with Micron and Nvidia edging lower. Traders remain cautious ahead of key economic data and events. Micron's earnings have negatively impacted the tech sector, while Nvidia's rally cools off. Bond yields have risen, and futures for major indices are slightly down. Several companies, including Micron, H.B. Fuller, Worthington Steel, Levi Strauss, Acuity Brands, Apogee Enterprises, McCormick, Walgreens Boots Alliance, and Nike, are in focus due to earnings reports.

Portfolio Pulse from Shanthi Rexaline

June 27, 2024 | 11:31 am

AMZN

BABA

JD

PDD

Amazon is launching a new section on its website for affordable fashion and lifestyle items, allowing Chinese sellers to ship directly to U.S. consumers. This move is seen as a counter to competition from PDD Holdings' Temu and Shein. As a result, Chinese e-commerce stocks like Alibaba, JD.com, and PDD are trading lower.

Portfolio Pulse from Anusuya Lahiri

June 27, 2024 | 11:22 am

CDE

Coeur Mining reported results from a multi-year exploration drilling and development program at the Kensington Underground Gold Mine in Southeast Alaska. Recent assays highlight the potential to extend its reserve-based mine life to over five years by year-end.

Portfolio Pulse from Benzinga Newsdesk

June 27, 2024 | 11:17 am